{"DataElement":{"publicId":"6074131","version":"1","preferredName":"Serological Hematology Hepatitis B Virus Core Antibody Polymerase Chain Reaction Laboratory Procedure Status","preferredDefinition":"Information related to the serological hematology laboratory test status for hepatitis B virus core antibody polymerase chain reaction.","longName":"6074127v1.0:2180457v2.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6074127","version":"1","preferredName":"Serological Hematology Hepatitis B Virus Core Antibody Polymerase Chain Reaction Laboratory Procedure","preferredDefinition":"Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens._The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof._An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection._A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"2634499v1.0:6074125v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2634499","version":"1","preferredName":"Serological Hematology","preferredDefinition":"Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.:Hematology; the branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","longName":"C41264:C16673","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serological","conceptCode":"C41264","definition":"Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematology","conceptCode":"C16673","definition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F570D6C-9995-13FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-04-30","modifiedBy":"ONEDATA","dateModified":"2007-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6074125","version":"1","preferredName":"Hepatitis B Virus Core Antibody Polymerase Chain Reaction Laboratory Procedure","preferredDefinition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.:A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C62797:C17003:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus Core Antibody","conceptCode":"C62797","definition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6596C1A2-E7AF-683C-E053-F662850ACB5A","latestVersionIndicator":"Yes","beginDate":"2018-02-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-02-19","modifiedBy":"ONEDATA","dateModified":"2018-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6596C1A2-E7C0-683C-E053-F662850ACB5A","latestVersionIndicator":"Yes","beginDate":"2018-02-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-02-19","modifiedBy":"MORENOC","dateModified":"2018-04-16","changeDescription":"04/16/2018: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180457","version":"2","preferredName":"Serological Hematology Test Status","preferredDefinition":"information related to the status serological hematology test.","longName":"SER_HEM_TST_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not tested","valueDescription":"No testing done","ValueMeaning":{"publicId":"2957556","version":"1","preferredName":"No testing done","longName":"2957556","preferredDefinition":"Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"772A4FB5-6D06-C581-E040-BB89AD431FF5","latestVersionIndicator":"Yes","beginDate":"2009-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F988BE-E248-B070-E040-BB89AD436C23","beginDate":"2007-04-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Inconclusive","valueDescription":"Inconclusive","ValueMeaning":{"publicId":"3079092","version":"1","preferredName":"Inconclusive","longName":"3079092","preferredDefinition":"Not putting an end to doubt or question; leading to no final results or outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inconclusive","conceptCode":"C75569","definition":"Not putting an end to doubt or question; leading to no final results or outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"854E41BC-82A6-C63E-E040-BB89AD435805","latestVersionIndicator":"Yes","beginDate":"2010-04-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F988BE-E1DB-B070-E040-BB89AD436C23","beginDate":"2007-04-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2617835","version":"1","preferredName":"Negative Finding","longName":"2617835","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CAF63D8-1F72-70DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-03-27","modifiedBy":"DWARZEL","dateModified":"2022-10-03","changeDescription":"Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F988BE-E1E5-B070-E040-BB89AD436C23","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"2931646","version":"1","preferredName":"Positive Finding","longName":"2931646","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7093A8D5-881C-C40D-E040-BB89AD437437","latestVersionIndicator":"Yes","beginDate":"2009-08-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-07","modifiedBy":"COLBERTM","dateModified":"2022-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F988BE-E1F9-B070-E040-BB89AD436C23","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7C48557-5804-E85A-E040-BB89AD43536D","beginDate":"2013-10-02","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-02","modifiedBy":"ONEDATA","dateModified":"2013-10-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F988BE-E19E-B070-E040-BB89AD436C23","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-01","modifiedBy":"COLBERTM","dateModified":"2022-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Hepatitis B core antibody PCR","type":"Preferred Question Text","description":"Hepatitis B core antibody PCR","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6596C273-D6C5-6846-E053-F662850A9C54","latestVersionIndicator":"Yes","beginDate":"2018-02-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-02-19","modifiedBy":"MORENOC","dateModified":"2018-04-16","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}